HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

Mostrar otras versiones (1)

BACKGROUND: Cardiovascular disease (CVD) is the most frequent cause of death in people with early stages of chronic kidney disease (CKD), for whom the absolute risk of cardiovascular events is similar to people who have existing coronary artery disease. This is an update of a review published in 200...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmer, Suetonia C., Navaneethan, Sankar D., Craig, Jonathan C., Johnson, David W., Perkovic, Vlado, Hegbrant, Jorgen, Strippoli, Giovanni F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2015
Materias:
Cochrane Highlights
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496564/
https://www.ncbi.nlm.nih.gov/pubmed/26760127
http://dx.doi.org/10.1590/1516-3180.20151336T2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496564/
https://www.ncbi.nlm.nih.gov/pubmed/26760127
http://dx.doi.org/10.1590/1516-3180.20151336T2

Ejemplares similares